These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1708148)

  • 1. Intra-midbrain raphe injections of the neurokinin-3 agonist senktide inhibit food and water intake in the rat.
    Paris JM; Mitsushio H; Lorens SA
    Pharmacol Biochem Behav; 1991 Jan; 38(1):223-6. PubMed ID: 1708148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-raphe neurokinin-induced hyperactivity: effects of 5,7-dihydroxytryptamine lesions.
    Paris JM; Mitsushio H; Lorens SA
    Brain Res; 1989 Jan; 476(1):183-8. PubMed ID: 2464417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elicitation of feeding, drinking, and gnawing following microinjections of muscimol into the median raphe nucleus of rats.
    Klitenick MA; Wirtshafter D
    Behav Neural Biol; 1989 May; 51(3):436-41. PubMed ID: 2730501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-median raphe infusions of muscimol and the substance P analogue DiMe-C7 produce hyperactivity: role of serotonin neurons.
    Paris JM; Lorens SA
    Behav Brain Res; 1987; 26(2-3):139-51. PubMed ID: 2447909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-raphe muscimol induced hyperactivity depends on ascending serotonin projections.
    Sainati SM; Lorens SA
    Pharmacol Biochem Behav; 1982 Nov; 17(5):973-86. PubMed ID: 6294690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tachykinin NH2-senktide inhibits alcohol intake in alcohol-preferring rats.
    Perfumi M; Polidori C; Pompei PL; De Caro G; Massi M
    Pharmacol Biochem Behav; 1991 Apr; 38(4):881-7. PubMed ID: 1714609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural consequences following infusion of selective neurokinin agonists into the median raphe nucleus of the rat.
    Mason GS; Elliott PJ
    Neuropharmacology; 1992 Aug; 31(8):757-60. PubMed ID: 1382245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies of the ingestive behaviors produced by microinjections of muscimol into the midbrain raphe nuclei of the ventral tegmental area of the rat.
    Klitenick MA; Wirtshafter D
    Life Sci; 1988; 42(7):775-82. PubMed ID: 3339955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose-response analysis of intra-raphe tachykinin-induced hyperactivity.
    Paris JM; Lorens SA
    J Pharmacol Exp Ther; 1989 Oct; 251(1):388-93. PubMed ID: 2795467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tachykinin NH2-senktide, a selective neurokinin B receptor agonist, is a very potent inhibitor of salt appetite in the rat.
    Massi M; Polidori C; Gentili L; Perfumi M; de Caro G; Maggi CA
    Neurosci Lett; 1988 Oct; 92(3):341-6. PubMed ID: 2462199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the behavioral activation produced by stimulation of GABAB receptors in the median raphe nucleus.
    Wirtshafter D; Stratford TR; Pitzer MR
    Behav Brain Res; 1993 Dec; 59(1-2):83-93. PubMed ID: 8155296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence against serotonin involvement in the hyperactivity produced by injections of muscimol into the median raphe nucleus.
    Wirtshafter D; Klitenick MA; Asin KE
    Pharmacol Biochem Behav; 1987 May; 27(1):45-52. PubMed ID: 2441421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forebrain lesions differentially affect drinking elicited by dipsogenic challenges and injections of muscimol into the median raphe nucleus.
    Stratford TR; Wirtshafter D
    Behav Neurosci; 2000 Aug; 114(4):760-71. PubMed ID: 10959535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscimol injections into the median raphe nucleus increase serum ACTH and corticosterone concentrations via a nonserotonergic mechanism.
    Paris JM; Lorens SA; Lee JM; Mitsushio H; Ritchie JC; Nemeroff CB
    Pharmacol Biochem Behav; 1991 Jul; 39(3):765-8. PubMed ID: 1723800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of food intake by kainate/quisqualate receptors in the median raphe nucleus.
    Wirtshafter D; Krebs JC
    Psychopharmacology (Berl); 1990; 101(1):137-41. PubMed ID: 2160664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tachykinin NK-1 and NK-3 selective agonists induce analgesia in the formalin test for tonic pain following intra-VTA or intra-accumbens microinfusions.
    Altier N; Stewart J
    Behav Brain Res; 1997 Dec; 89(1-2):151-65. PubMed ID: 9475623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the central tachykinin receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats.
    Itoi K; Tschöpe C; Jost N; Culman J; Lebrun C; Stauss B; Unger T
    Eur J Pharmacol; 1992 Sep; 219(3):435-44. PubMed ID: 1385176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-raphe benzodiazepines enhance rat locomotor activity: interactions with GABA.
    Sainati SM; Lorens SA
    Pharmacol Biochem Behav; 1983 Mar; 18(3):407-14. PubMed ID: 6132411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GABAB receptor agonist baclofen administered into the median and dorsal raphe nuclei is rewarding as shown by intracranial self-administration and conditioned place preference in rats.
    Shin R; Ikemoto S
    Psychopharmacology (Berl); 2010 Mar; 208(4):545-54. PubMed ID: 20054525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists.
    Elliott PJ; Mason GS; Stephens-Smith M; Hagan RM
    Neuropeptides; 1991 Jun; 19(2):119-26. PubMed ID: 1719444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.